2023-06-01 2024-05-31 false Capium Accounts Production 1.1 13377995 2023-06-01 2024-05-31 13377995 bus:AbridgedAccounts 2023-06-01 2024-05-31 13377995 bus:FRS102 2023-06-01 2024-05-31 13377995 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 13377995 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 13377995 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 13377995 2023-06-01 2024-05-31 13377995 2024-05-31 13377995 bus:RegisteredOffice 2023-06-01 2024-05-31 13377995 core:WithinOneYear 2024-05-31 13377995 core:AfterOneYear 2024-05-31 13377995 1 2023-06-01 2024-05-31 13377995 bus:Director1 2023-06-01 2024-05-31 13377995 bus:Director1 2024-05-31 13377995 bus:Director1 2022-06-01 2023-05-31 13377995 2022-06-01 13377995 bus:LeadAgentIfApplicable 2023-06-01 2024-05-31 13377995 2022-06-01 2023-05-31 13377995 2023-05-31 13377995 core:WithinOneYear 2023-05-31 13377995 core:AfterOneYear 2023-05-31 13377995 bus:EntityAccountantsOrAuditors 2022-06-01 2023-05-31 13377995 bus:OrdinaryShareClass1 2023-06-01 2024-05-31 13377995 bus:OrdinaryShareClass1 2024-05-31 13377995 bus:OrdinaryShareClass1 2022-06-01 2023-05-31 13377995 bus:OrdinaryShareClass1 2023-05-31 13377995 core:MotorCars 2023-06-01 2024-05-31 13377995 core:MotorCars 2024-05-31 13377995 core:MotorCars 2023-05-31 13377995 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-31 13377995 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-05-31 13377995 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 13377995 core:CostValuation core:Non-currentFinancialInstruments 2023-05-31 13377995 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-05-31 13377995 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 13377995 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 13377995 core:Non-currentFinancialInstruments 2024-05-31 13377995 core:Non-currentFinancialInstruments 2023-05-31 13377995 core:ShareCapital 2024-05-31 13377995 core:ShareCapital 2023-05-31 13377995 core:RetainedEarningsAccumulatedLosses 2024-05-31 13377995 core:RetainedEarningsAccumulatedLosses 2023-05-31 13377995 dpl:Item1 2023-06-01 13377995 dpl:Item1 2024-05-31 13377995 dpl:Item1 2022-06-01 13377995 dpl:Item1 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13377995
England and Wales

 

 

 

AMY MEDICAL LTD


Abridged Accounts
 


Period of accounts

Start date: 01 June 2023

End date: 31 May 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 44,825    59,767 
44,825    59,767 
Current assets      
Cash at bank and in hand 42,221    49,439 
Creditors: amount falling due within one year (22,179)   (4,692)
Net current assets 20,042    44,747 
 
Total assets less current liabilities 64,867    104,514 
Creditors: amount falling due after more than one year (59,074)   (67,690)
Net assets 5,793    36,824 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 5,792    36,823 
Shareholders' funds 5,793    36,824 
 


For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 24 January 2025 and were signed by:


-------------------------------
Shazia Siddique
Director
1
General Information
Amy Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 13377995, registration address 87 Emmeline Avenue, Ebbsfleet Valley, Swanscombe, England, DA10 1EA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 01 June 2023 79,690    79,690 
Additions  
Disposals  
At 31 May 2024 79,690    79,690 
Depreciation
At 01 June 2023 19,923    19,923 
Charge for year 14,942    14,942 
On disposals  
At 31 May 2024 34,865    34,865 
Net book values
Closing balance as at 31 May 2024 44,825    44,825 
Opening balance as at 01 June 2023 59,767    59,767 


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
1 Class A share of £1.00 each  
 

2